Medivir’s Annual Report for 2018 is published

Stockholm, Sweden - Medivir AB (Nasdaq Stockholm: MVIR) today announces that the Annual Report for 2018 now is available at the company’s website: www.medivir.com 2018 was transformative year for Medivir. We managed to successfully move the projects in our clinical portfolio forward. We also decided on an increased focus on the further development of our clinical portfolio. This resulted in a reorganization where the company’s administration and its activities in preclinical research were reduced and Medivir could enter 2019 with a slimmed organization that has a clear focus on the